Curcumin Microcapsule Formulations for Prolong Persistence in the Photodynamic Inactivation of Aedes aegypti Larvae

<b>Background:</b> Viral diseases including dengue, zika, chikungunya, and yellow fever remain a significant public health challenge, primarily due to the increasing resistance of these vectors, the <i>Aedes aegypti</i> mosquito, to conventional control methods. <b>Objectives:</b> Herein, a microencapsulated curcumin formulation was developed and characterized using spray-drying technology, with D-mannitol and starch as encapsulating agents. After microencapsulation, photolarvicidal tablet formulations (Formulated Curcumin Tablets-FCT) were prepared, varying the proportions of starch and pectin: FCT1 (60% starch), FCT2 (35% pectin and 25% starch), and FCT3 (42.5% pectin and 17.5% starch), while maintaining 10% curcumin and 30% D-mannitol in all formulations. The main goal was to enhance the stability and efficacy of curcumin as a photolarvicidal agent. <b>Methods:</b> The formulation was characterized by UV-Vis spectroscopy, confocal microscopy, thermal analysis (TG and DSC), scanning electron microscopy (SEM), fourier transform infrared spectroscopy (FTIR), and photodegradation assays under fluorescent light. <b>Results:</b> The photodynamic inactivation (PDI) of <i>Ae. aegypti</i> larvae was evaluated under white, fluorescent light exposure, and the formulation exhibited a significantly enhanced larvicidal activity compared to free curcumin, with a 57-fold reduction in LC<sub>50</sub> (LC<sub>50-24h</sub> = 0.27 mg/L). Additionally, the most effective formulation, FCT2, maintained its residual activity for 27 days, reinforcing that curcumin microencapsulation, combined with PDI, can extend vector control. Release studies under different pH conditions confirmed a controlled release mechanism, favoring environmental stability. <b>Conclusions:</b> The results indicate that microencapsulated curcumin has great potential as a sustainable photoinsecticidal agent, offering stability, efficacy, and a promising alternative for managing <i>Ae. aegypti</i> larval populations.

Authors

Institutions

Publication Details

Journal
Pharmaceutics
Published
2025-04-09
DOI
https://doi.org/10.3390/pharmaceutics17040496
Citations
1
Primary Topic
Curcumin's Biomedical Applications
Type
article
Field-Weighted Citation Impact
0.59
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Curcumin Microcapsule Formulations for Prolong Persistence in the Photodynamic Inactivation of Aedes aegypti Larvae

Francisco Eduardo Gontijo Guimarães, Natália Mayumi Inada, Alessandra Ramos Lima, Matheus Garbuio et al.
1 citations
Pharmaceutics
Curcumin's Biomedical Applications
0.59
article

Curcumin Microcapsule Formulations for Prolong Persistence in the Photodynamic Inactivation of Aedes aegypti Larvae

Francisco Eduardo Gontijo Guimarães, Natália Mayumi Inada, Alessandra Ramos Lima, Matheus Garbuio, Edgar Aparecido Sanches, Vanderlei Salvador Bagnato, Hernane da Silva Barud, Larissa Marila de Souza, Lucas D. Dias, Ana Paula da Silva, Jean Carlos Ferreira Machado
article en
1 citations

Abstract

<b>Background:</b> Viral diseases including dengue, zika, chikungunya, and yellow fever remain a significant public health challenge, primarily due to the increasing resistance of these vectors, the <i>Aedes aegypti</i> mosquito, to conventional control methods. <b>Objectives:</b> Herein, a microencapsulated curcumin formulation was developed and characterized using spray-drying technology, with D-mannitol and starch as encapsulating agents. After microencapsulation, photolarvicidal tablet formulations (Formulated Curcumin Tablets-FCT) were prepared, varying the proportions of starch and pectin: FCT1 (60% starch), FCT2 (35% pectin and 25% starch), and FCT3 (42.5% pectin and 17.5% starch), while maintaining 10% curcumin and 30% D-mannitol in all formulations. The main goal was to enhance the stability and efficacy of curcumin as a photolarvicidal agent. <b>Methods:</b> The formulation was characterized by UV-Vis spectroscopy, confocal microscopy, thermal analysis (TG and DSC), scanning electron microscopy (SEM), fourier transform infrared spectroscopy (FTIR), and photodegradation assays under fluorescent light. <b>Results:</b> The photodynamic inactivation (PDI) of <i>Ae. aegypti</i> larvae was evaluated under white, fluorescent light exposure, and the formulation exhibited a significantly enhanced larvicidal activity compared to free curcumin, with a 57-fold reduction in LC<sub>50</sub> (LC<sub>50-24h</sub> = 0.27 mg/L). Additionally, the most effective formulation, FCT2, maintained its residual activity for 27 days, reinforcing that curcumin microencapsulation, combined with PDI, can extend vector control. Release studies under different pH conditions confirmed a controlled release mechanism, favoring environmental stability. <b>Conclusions:</b> The results indicate that microencapsulated curcumin has great potential as a sustainable photoinsecticidal agent, offering stability, efficacy, and a promising alternative for managing <i>Ae. aegypti</i> larval populations.

PharmaceuticsVol. 17(4)
Universidade Federal de São Carlos (BR), Universidade de São Paulo (BR), Universidade Evangelica de Goiás (BR), Centro Universitário de Araraquara (BR), Universidade Federal do Amazonas (BR), Texas A&M University (US)
Openalex Percentile: Top 37%
Curcumin's Biomedical Applications
0.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.